Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule

Ola Lindén; F Tennvall; Eva Cavallin-Ståhl; Lennart Darte; Tomas G Ohlsson; Cecilia Hindorf; Karin Wingårdh; Sven-Erik Strand

Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule

Ola Lindén, F Tennvall, Eva Cavallin-Ståhl, Lennart Darte, Tomas G Ohlsson, Cecilia Hindorf, Karin Wingårdh, Sven-Erik Strand

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	602A-602A
Journal	Blood
Volume	98
Issue number	11
Publication status	Published - 2001

Subject classification (UKÄ)

Hematology

Cite this

@article{91742a476b56462e95a8a56443459269,

title = "Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule",

author = "Ola Lind{\'e}n and F Tennvall and Eva Cavallin-St{\aa}hl and Lennart Darte and Ohlsson, {Tomas G} and Cecilia Hindorf and Karin Wing{\aa}rdh and Sven-Erik Strand",

year = "2001",

language = "English",

volume = "98",

pages = "602A--602A",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule

AU - Lindén, Ola

AU - Tennvall, F

AU - Cavallin-Ståhl, Eva

AU - Darte, Lennart

AU - Ohlsson, Tomas G

AU - Hindorf, Cecilia

AU - Wingårdh, Karin

AU - Strand, Sven-Erik

PY - 2001

Y1 - 2001

M3 - Article

SN - 1528-0020

VL - 98

SP - 602A-602A

JO - Blood

JF - Blood

IS - 11

ER -